1. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor;Aoki;J Pharmacol Exp Ther,2001
2. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity;Aoki;J Pharmacol Exp Ther,2000
3. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation;Ariga;J Immunol,2004
4. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers;Barber;Am J Physiol Lung Cell Mol Physiol,2004
5. How corticosteroids control inflammation: Quintiles Prize Lecture 2005;Barnes;Br J Pharmacol,2006a